Reaction

Mucormycosis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,541 reports · 115 co-occurring drugs

As of the last recalculation, Mucormycosis appears in 2,541 FAERS reports alongside 115 co-occurring drug terms. The strongest observed disproportionality signal is AMPHOTERICIN B (PRR 182.8).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Amphotericin B	252	182.8	186.5
Voriconazole Injection	331	143.4	145.6
Basiliximab	188	141.3	143.6
Posaconazole Delayed-Release	169	135.0	137.1
Voriconazole	358	112.2	113.5
Posaconazole	185	100.5	101.7
Micafungin Sodium	99	99.5	100.7
Valganciclovir Hydrochloride Powder,	126	89.0	89.9
Tacrolimus Ointment 0.1%	756	70.4	70.8
Tacrolimus Extended-Release Capsules	756	70.2	70.6
Valganciclovir	136	62.4	62.8
Valganciclovir Hydrochloride	136	62.4	62.8
Tacrolimus	798	60.4	60.7
Anti-Thymocyte Globulin (Rabbit)	56	58.1	58.5
Remdesivir	84	53.4	53.7
Busulfan	92	49.7	49.9
Pegaspargase	68	46.7	47.0
Mycophenolate Mofetil	585	45.5	45.7
Mycophenolate Mofetil Hydrochloride	585	45.5	45.6
Mycophenilic Acid	106	43.7	43.9
Meropenem	143	38.6	38.8
Ganciclovir	47	38.3	38.5
Fluconazole	287	37.7	37.8
Ganciclovir Sodium	47	37.0	37.2
Fludarabine Phosphate	159	35.3	35.4
Cefepime	58	33.9	34.0
Cytarabine	226	33.7	33.8
Piperacillin And Tazobactam	50	32.6	32.8
Methylprednisolone	435	30.9	31.0
Atovaquone	30	30.9	31.0
Cefepime Hydrochloride	59	30.7	30.8
Piperacillin Sodium,Tazobactam Sodium	90	28.8	28.9
Mycophenolic Acid	106	28.3	28.4
Thiotepa	31	26.9	27.0
Mercaptopurine	53	25.5	25.6
Ceftriaxone	88	22.7	22.8
Amikacin	44	21.5	21.5
Piperacillin Sodium And Tazobactam Sodium	50	21.3	21.3
Vancomycin	139	20.8	20.8
Vancomycin Hydrochloride	149	19.6	19.7
Ceftriaxone Sodium	88	19.4	19.5
Norepinephrine	24	18.6	18.6
Nystatin Ointment	58	18.5	18.6
Nystatin Cream	58	18.5	18.5
Nystatin	58	17.8	17.8
Prednisolone	337	17.5	17.5
Prednisolone Oral	337	17.5	17.5
Prednisolone Oral Solution	337	17.5	17.5
Azacitidine For	36	16.4	16.5
Daptomycin	18	16.1	16.1
Norepinephrine Bitartrate	27	15.5	15.5
Gentamicin	24	15.2	15.2
Cyclophosphamide Injection, Solution	291	15.1	15.1
Cyclophosphamide	291	15.1	15.1
Cyclophosphamide For Injection	291	15.1	15.1
Ampicillin	15	14.9	14.9
Ampicillin Sodium	15	14.9	14.9
Sirolimus	24	14.7	14.7
Vincristine Sulfate	51	14.5	14.6
Gentamicin Sulfate	27	14.1	14.2
Itraconazole	20	14.1	14.2
Dexamethasone 1.5 Mg	409	13.4	13.5
Dexamethasone	409	13.3	13.3
Azithromycin	62	12.9	12.9
Etoposide	111	12.9	12.9
Blinatumomab	16	12.6	12.7
Azithromycin Monohydrate	62	12.5	12.5
Linezolid	44	12.3	12.3
Azacitidine	43	12.1	12.1
Cyclosporine	151	11.8	11.8
Axicabtagene Ciloleucel	13	10.8	10.9
Prednisone	524	10.5	10.5
Levofloxacin	74	10.3	10.3
Levofloxacin In 5% Dextrose	74	10.3	10.3
Methylprednisolone Acetate	10	10.3	10.3
Cefazolin	11	9.9	9.9
Alemtuzumab	22	9.4	9.4
Moxifloxacin	16	9.4	9.4
Clindamycin	31	9.0	9.1
Azithromycin Dihydrate	62	8.8	8.9
Methylprednisolone Sodium Succinate	49	8.8	8.8
Insulin	58	8.7	8.7
Doxorubicin Hydrochloride	34	8.6	8.6
Acyclovir	112	8.4	8.4
Cefazolin Sodium	12	8.2	8.2
Isoniazid	16	8.1	8.1
Doxorubicin	85	8.0	8.1
Clindamycin Phosphate	32	7.9	7.9
Venetoclax	57	7.7	7.7
Ifosfamide	20	7.7	7.7
Melphalan	21	7.6	7.6
Anakinra	15	7.4	7.5
Rifampicin	9	7.3	7.3
Oseltamivir	7	7.2	7.2
Melphalan Hydrochloride	20	6.6	6.6
Moxifloxacin Hydrochloride	16	6.5	6.5
Terbinafine Hydrochloride	7	6.5	6.5
Rituximab	153	6.2	6.2
Methotrexate	286	6.1	6.2
0Xygen	36	6.1	6.1
Oxygen	36	6.1	6.1
Valacyclovir	28	5.5	5.6
Filgrastim	25	5.5	5.5
Cladribine	6	5.1	5.1
Tobramycin Solution	7	4.8	4.8
Imatinib Mesylate	16	4.7	4.7
Tocilizumab	64	4.7	4.7
Tobramycin Sulfate	7	4.6	4.6
Ibrutinib	45	4.6	4.6
Pyrazinamide	5	4.4	4.4
Deferasirox	14	4.3	4.3
Sorafenib	10	4.0	4.0
Daratumumab	19	3.9	3.9
Obinutuzumab	7	3.5	3.5
Bendamustine Hydrochloride	5	3.4	3.4

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.